EN | RU
EN | RU

Help Support

Back

Personified analgesic therapy- a new hope for pain management

Personified analgesic therapy- a new hope for pain management Personified analgesic therapy- a new hope for pain management
Personified analgesic therapy- a new hope for pain management Personified analgesic therapy- a new hope for pain management

What's new?

Personalized analgesic therapy considering individual symptoms and diagnosis holds promise in effective pain management.

According to a study published in a professional monothematic journal for practising doctors, Medical Council, personalization of therapy emerging as a strong foothold in modern medicine. This approach referring an individual strategy to each patient, consider individual symptoms of the patient and the particular clinical case.

This strategy should also be used to design rational analgesic therapy to treat patients with the most prevalent and socially significant ailments. Experts of different specialities like cardiologists, rheumatologists, clinical pharmacologists, and neurologists acknowledged the key perspectives of the prescription of NSAIDs, a widely used drug class of painkillers, comprising those employed to provide relief from musculoskeletal pain.

The practitioner should consider medical history data, diagnosis, the intensity of pain, the presence of comorbid diseases, risk factors for drug complications, and the planned duration of analgesic therapy while choosing NSAIDs. There are various types of NSAIDs; some are suitable for long-term pain management in chronic diseases like Etoricoxib and others for urgent acute pain therapy like Ketoprofen. The things to keep in consideration before treatment are patient safety, preventing NSAID associated complications and the duration of the particular drug administration authorized by the patient information leaflet. Further, as per recent findings, the launch of a new generic Etoricoxib extends the opportunities of analgesic therapy in Russia. 

Source:

Medical Council

Article:

Personification Of The Use Of Nonsteroidal Anti-Inflammatory Drugs For Musculoskeletal Diseases. Resolution On The Results Of The Expert Meeting Of December 13, 2017

Authors:

A.E. KARATEEV et al.

Comments (0)

Recommendations

You want to delete this comment? Please mention comment Invalid Text Content Text Content cannot me more than 1000 Something Went Wrong Cancel Confirm Confirm Delete Hide Replies View Replies View Replies en
Try: